![Christopher Boerner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Boerner
Chief Executive Officer at
BRISTOL-MYERS SQUIBB COMPANY
Net worth: 9 M $ as of 2026-05-30
Profile
Christopher S.
Boerner is Chairman & Chief Executive Officer at Bristol Myers Squibb Co. since 2024.
Dr. Boerner is Director at Capital Health System, Inc. Dr. Boerner is Independent Director at Colgate-Palmolive Co. starting 2026.
Dr. Boerner is Director at Pharmaceutical Research & Manufacturers of America.
Formerly, Dr. Boerner was Marketing Director at Genentech, Inc. in 2010.
Dr. Boerner was Independent Director at Achaogen, Inc. from 2014 to 2015.
Dr. Boerner was Vice President-Marketing at Dendreon Corp.
in 2010.
Dr. Boerner was Executive Vice President-Commercial at Seagen, Inc. from 2014 to 2015.
Dr. Boerner was Associate at McKinsey & Co., Inc. Dr. Boerner completed undergraduate studies at Washington University in St. Louis.
Dr. Boerner earned graduate and doctorate degrees from Haas School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-11 | 146,890 ( 0.01% ) | 8 M $ | 2026-05-30 | |
| 2026-05-10 | 1,383 ( 0% ) | 124 650 $ | 2026-05-30 |
Latest news about Christopher Boerner
Christopher Boerner active positions
| Companies | Position | Start |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Chief Executive Officer | 2023-10-31 |
| COLGATE-PALMOLIVE COMPANY | Director/Board Member | 2026-03-14 |
Capital Health System, Inc.
 Capital Health System, Inc. Hospital/Nursing ManagementHealth Services Owns and operates hospitals | Director/Board Member | - |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Director/Board Member | - |
Former positions of Christopher Boerner
| Companies | Position | End |
|---|---|---|
| ACHAOGEN | Director/Board Member | 2015-06-09 |
| SEAGEN INC. | Corporate Officer/Principal | 2015-01-29 |
| DENDREON CORPORATION | Sales & Marketing | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Sales & Marketing | 2009-12-31 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | - |
Training of Christopher Boerner
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
71
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Colgate-Palmolive Co.
 Colgate-Palmolive Co. Household/Personal CareConsumer Non-Durables Manufactures and sells oral, personal, home care & pet nutritional products | Consumer Non-Durables |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Capital Health System, Inc.
Capital Health System, Inc. Hospital/Nursing ManagementHealth Services Owns and operates hospitals | Health Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Christopher Boerner
